Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Mitglied/er, Innere Klinik (Tumorforschung)
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
-
2013 WS
-
2013 SS
-
2012 WS
-
2012 SS
-
2011 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume MarginIn: JAMA Network Open Jg. 6 (2023) Nr. 3, S. e234066ISSN: 2574-3805Online Volltext: dx.doi.org/ (Open Access)
-
MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy : imaging remission criteria and volumetric regression kineticsIn: Scientific Reports Jg. 13 (2023) Nr. 1,ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma : the study protocol of the Adrisk trialIn: Frontiers in Oncology Jg. 13 (2023)ISSN: 2234-943XOnline Volltext: dx.doi.org/ (Open Access)
-
Respiration-controlled radiotherapy in lung cancer : Systematic evaluation of the optimal application practiceIn: Clinical and Translational Radiation Oncology Jg. 40 (2023)ISSN: 2405-6308Online Volltext: dx.doi.org/ (Open Access)
-
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factorsIn: Immunotherapy Jg. 14 (2022) Nr. 12, S. 927 - 944ISSN: 1750-743X; 1750-7448Online Volltext: dx.doi.org/ (Open Access)
-
Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy : Results from a longitudinal studyIn: Hematological Oncology (2022) in pressISSN: 0278-0232; 1099-1069Online Volltext: dx.doi.org/ (Open Access)
-
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatmentIn: Radiation Oncology Jg. 17 (2022) Nr. 1,ISSN: 1748-717XOnline Volltext: dx.doi.org/ (Open Access)
-
Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CTIn: Scientific Reports Jg. 12 (2022) Nr. 1,ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID TrialIn: Oncology Research and Treatment Jg. 45 (2022) Nr. 6, S. 319 - 325ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/
-
Systemic therapy in metastatic renal cell carcinoma (mRCC) : an evidence-based recommendation of the German interdisciplinary RCC guidelines groupIn: World Journal of Urology Jg. 40 (2022) Nr. 10, S. 2381 - 2386ISSN: 1433-8726; 0724-4983Online Volltext: dx.doi.org/ (Open Access)
-
Behandlungsrealität des kleinzelligen Lungenkarzinoms in Deutschland – das CRISP-RegisterIn: Der Onkologe Jg. 27 (2021) Nr. 9, S. 911 - 916ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapyIn: The Pharmacogenomics Journal Jg. 21 (2021) Nr. 2, S. 273ISSN: 1473-1150; 1470-269XOnline Volltext: dx.doi.org/ (Open Access)
-
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trialIn: Radiation Oncology Jg. 16 (2021) Nr. 1, S. 59ISSN: 1748-717XOnline Volltext: dx.doi.org/ (Open Access)
-
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trialIn: Journal of Applied Clinical Medical Physics Jg. 22 (2021) Nr. 1, S. 242 - 250ISSN: 1526-9914Online Volltext: dx.doi.org/ (Open Access)
-
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapyIn: The Pharmacogenomics Journal Jg. 21 (2021) Nr. 1, S. 37 - 46ISSN: 1473-1150; 1470-269XOnline Volltext: dx.doi.org/ (Open Access)
-
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including CetuximabIn: Frontiers in Oncology Jg. 11 (2021)ISSN: 2234-943XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Investigation of the Effect of Radiotherapy Prior to Initiation of Treatment with Nivolumab in Patients with Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HSCCN) - Real-World Data from the non-interventional Study (NIS) HANNAIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 107 - S108ISSN: 1439-099X; 0179-7158
-
Modification of total nodal Irradiation (TNI) as Part of Conditioning prior to allogeneic Stem Cell Transplantation (aSCT) for hematological Diseases using helical Tomotherapy or IMRT based on a retrospective CohortIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 173ISSN: 1439-099X; 0179-7158
-
Patterns of cervical lymph node metastasis in supraglottic laryngeal cancer and therapeutic implications of surgical staging of the neckIn: European Archives of Oto-Rhino-Laryngology and Head & Neck Jg. 278 (2021) Nr. 12, S. 5021 - 5027ISSN: 1434-4726; 0937-4477Online Volltext: dx.doi.org/ (Open Access)
-
Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definitionIn: Radiation Oncology Jg. 16 (2021) Nr. 1,ISSN: 1748-717XOnline Volltext: dx.doi.org/ (Open Access)
-
Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and GermanyIn: Head and Neck Jg. 43 (2021) Nr. 11, S. 3540 - 3551ISSN: 1097-0347; 1043-3074; 0148-6403Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive ChemoradiotherapyIn: Journal of Nuclear Medicine (JNM) / Society of Nuclear Medicine and Molecular Imaging (SNMMI) (Hrsg.) Jg. 62 (2021) Nr. 12, S. 1684 - 1691ISSN: 1535-5667; 0161-5505; 2159-662X; 0022-3123; 0097-9058Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma : An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer SocietyIn: Oncology Research and Treatment Jg. 43 (2020) Nr. 7-8, S. 333 - 338ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ (Open Access)
-
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment : Only few risks left to improveIn: European Journal of Cancer Jg. 138 (2020) S. 156 - 168ISSN: 1879-0852; 0959-8049Online Volltext: dx.doi.org/
-
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapyIn: The Pharmacogenomics Journal Jg. 21 (2020) Nr. 1, S. 37 - 46ISSN: 1470-269X; 1473-1150Online Volltext: dx.doi.org/ (Open Access)
-
Impact of ¹⁸F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients : A prospective evaluation of staging algorithmsIn: European Journal of Radiology Jg. 128 (2020) S. 108975ISSN: 1872-7727; 0720-048XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Nivolumab versus everolimus in patients with advanced renal cell carcinoma : Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trialIn: Cancer (2020)ISSN: 1097-0142; 0008-543XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic : recommendations from the interdisciplinary working group for renal tumors (IAG-N)In: Journal of Cancer Research and Clinical Oncology Jg. 146 (2020) Nr. 11, S. 3075 - 3078ISSN: 1432-1335Online Volltext: dx.doi.org/ (Open Access)
-
Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck : Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trialIn: Oral Oncology Jg. 97 (2019) S. 82 - 91ISSN: 1879-0593; 1368-8375Online Volltext: dx.doi.org/
-
Afatinib vs Placebo as Adjuvant Therapy after Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck : A Randomized Clinical TrialIn: JAMA Oncology Jg. 5 (2019) Nr. 8, S. 1170 - 1180ISSN: 2374-2445; 2374-2437Online Volltext: dx.doi.org/ (Open Access)
-
Cerebral Recurrence after trimodal Therapy of Patients with locally advanced NSCLC - Prognostic Factors and prognostic ImportanceIn: Strahlentherapie und Onkologie Jg. 195 (2019) Nr. Suppl. 1, S. S66 - S67ISSN: 0179-7158; 1439-099X
-
Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD) : an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)In: European Journal of Cancer (EJC) Jg. 122 (2019) S. 53 - 60ISSN: 1879-0852; 0959-8049; 1879-2995Online Volltext: dx.doi.org/
-
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors : results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study GroupIn: Journal of Cancer Research and Clinical Oncology Jg. 145 (2019) Nr. 3, S. 717 - 723ISSN: 1432-1335; 0171-5216Online Volltext: dx.doi.org/
-
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 7, S. 1439 - 1447ISSN: 1619-7089; 1619-7070; 0340-6997Online Volltext: dx.doi.org/
-
Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 TrialIn: International Journal of Radiation Oncology, Biology, Physics Jg. 105 (2019) Nr. 1, Supplement, S. 146 - S147ISSN: 1879-355XOnline Volltext: dx.doi.org/ (Open Access)
-
An interdisciplinary consensus on the management of bone metastases from renal cell carcinomaIn: Nature Reviews Urology Jg. 15 (2018) Nr. 8, S. 511 - 521ISSN: 1759-4820; 1759-4812Online Volltext: dx.doi.org/ (Open Access)
-
Erratum to “CheckMate 025 Randomized Phase 3 Study : Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma”In: European Urology Jg. 73 (2018) Nr. 4, S. e116 - e118ISSN: 1421-993X; 0302-2838Online Volltext: dx.doi.org/
-
Final Re-irradiation of Patients with NSCLC after primary high-dose Local TherapyIn: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl.1, S. S59ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
Investigations of Long-term Survivors with locally advanced NSCLC on Morbidity of curative Therapy - Analysis of neurocognitive EffectsIn: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl. 1, S. 110ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 StudyIn: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl.1, S. S41 - S42ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
Pretreatment metabolic volume in PET : Prognostic in lung cancer? German ESPATUE randomised phase3trialIn: Radiotherapy and Oncology (The Green Journal) Jg. 127 (2018) Nr. Suppl.1, S. S253 - S254ISSN: 1879-0887; 0167-8140Online Volltext: dx.doi.org/ (Open Access)
-
Sequential Dose Escalation Study NEOAHA for locally advanced NSCLC - Phase I-Results of Stage 1 (Integrated Boost-Radiation in neoadjuvant Therapy)In: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl. 1, S. S23 - S24ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancerIn: Annals of Oncology Jg. 28 (2017) Nr. 10, S. 2526 - 2532ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ (Open Access)
-
CheckMate 025 Randomized Phase 3 Study : Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell CarcinomaIn: European Urology Jg. 72 (2017) Nr. 6, S. 962 - 971ISSN: 1421-993X; 0302-2838Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Factors for the long-term Survival of Patients with NSCLC in the Stage of oligometastatic Disease after definitive Local TherapyIn: Strahlentherapie und Onkologie Jg. 193 (2017) Nr. Suppl. 1, S. 58ISSN: 0179-7158; 1439-099X
-
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trialIn: Annals of Oncology Jg. 28 (2017) Nr. 5, S. 1084 - 1089ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ (Open Access)
-
Population modeling integrating pharmacokinetics, pharmacodynamics, pharmacogenetics, and clinical outcome in patients with sunitinib-treated cancerIn: CPT: Pharmacometrics and Systems Pharmacology Jg. 6 (2017) Nr. 9, S. 604 - 613ISSN: 2163-8306Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic Significance of Mean Lung Dose (MLD) in the dose-enhanced Radiochemotherapy of Local Advanced NSCLC - Analysis of ESPATU's Definitive Radiochemotherapy ArmIn: Strahlentherapie und Onkologie Jg. 193 (2017) Nr. 1, S. 20ISSN: 0179-7158; 1439-099X
-
Systemic therapy in metastatic renal cell carcinomaIn: World Journal of Urology Jg. 35 (2017) Nr. 2, S. 179 - 188ISSN: 1433-8726; 0724-4983Online Volltext: dx.doi.org/ (Open Access)
-
Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to (18)F-FDG PET/CT?In: European Radiology Jg. 27 (2017) Nr. 2, S. 681 - 688ISSN: 0938-7994; 1432-1084Online Volltext: dx.doi.org/
-
A Single-Institution Analysis of the Surgical Management of Pulmonary Large Cell Neuroendocrine CarcinomasIn: The Annals of Thoracic Surgery Jg. 101 (2016) Nr. 5, S. 1909 - 1914ISSN: 0003-4975; 1552-6259Online Volltext: dx.doi.org/
-
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma : subgroup analysis of the LUX-Head & Neck 1 trialIn: Annals of Oncology Jg. 27 (2016) Nr. 8, S. 1585 - 1593ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access)
-
CheckMate 025 phase III trial : Outcomes by key baseline factors and prior therapy for nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)In: Journal of Clinical Oncology Jg. 34 (2016) Nr. 2 Suppl., S. 498ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Circulating Tumor Cell Composition in Renal Cell CarcinomaIn: PLoS ONE Jg. 11 (2016) Nr. 4, S. e0153018ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patientsIn: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 4, S. 795 - 805ISSN: 0171-5216Online Volltext: dx.doi.org/
-
Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment : Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung CancerIn: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. 21, S. 2526 - 2533ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Tumor Biomarker Association With Clinical Outcomes in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Patients (Pts) Treated With Afatinib Versus Methotrexate (MTX) : LUX-Head & Neck 1 (LHN1)In: International Journal of Radiation Oncology Biology Physics Jg. 94 (2016) Nr. 4, S. 868 - 869ISSN: 0360-3016Online Volltext: dx.doi.org/
-
Two-year efficacy and safety update from the phase III CheckMate 025 study of nivolumab versus everolimus in patients with advanced renal cell carcinoma (aRCC)In: BJU International Jg. 118 (2016) Nr. Suppl. 5, S. 11 - 12ISSN: 1464-4096; 1464-410XOnline Volltext: dx.doi.org/
-
A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma : A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN)In: European Journal of Cancer Jg. 51 (2015) Nr. Suppl.3, S. 517ISSN: 0959-8049Online Volltext: dx.doi.org/
-
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neckIn: Cancer chemotherapy and pharmacology Jg. 76 (2015) Nr. 1, S. 13 - 20ISSN: 0344-5704; 1432-0843Online Volltext: dx.doi.org/
-
Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyIn: Journal of Thoracic Disease Jg. 7 (2015) Nr. 3, S. 264 - 272ISSN: 2072-1439Online Volltext: dx.doi.org/
-
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1) : an open-label, randomised phase 3 trialIn: The Lancet Oncology Jg. 16 (2015) Nr. 5, S. 583 - 594ISSN: 1470-2045; 1474-5488Online Volltext: dx.doi.org/
-
Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patientsIn: European journal of cancer Jg. 51 (2015) Nr. 12, S. 1596 - 1602ISSN: 1879-0852; 1879-2995; 0959-8049Online Volltext: dx.doi.org/
-
Biomarker analysis in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients (pts) treated with second-line afatinib versus methotrexate (MTX) : LUX-Head & Neck 1 (LUX-H&N1)In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15 Suppl., S. 6023ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
CheckMate 025 : a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)In: BJU International (BJUI) Jg. 116 (2015) Nr. S 5: Fourteenth International Kidney Cancer Symposium Miami Marriott Biscayne Bay, Miami, Florida 6–7 November 2015 : Abstracts, S. 17ISSN: 1464-410X; 1464-4096Online Volltext: dx.doi.org/
-
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer : a multi-tumour, multi-institutional phase II studyIn: Annals of oncology Jg. 26 (2015) Nr. 3, S. 598 - 607ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/
-
Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer : a subgroup analysis from AIO-PK0104In: Acta Oncologica Jg. 54 (2015) Nr. 7, S. 993 - 1000ISSN: 1651-226X; 0284-186XOnline Volltext: dx.doi.org/ (Open Access)
-
Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapiesIn: Oral Oncology Jg. 51 (2015) Nr. 5, S. e39ISSN: 1879-0593; 1368-8375Online Volltext: dx.doi.org/
-
Nivolumab versus Everolimus in Advanced Renal-Cell CarcinomaIn: The New England Journal of Medicine Jg. 373 (2015) Nr. 19, S. 1803 - 1813ISSN: 1533-4406; 0028-4793Online Volltext: dx.doi.org/
-
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced non-small cell lung cancer (NSCLC) patientIn: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 8051ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ Online Volltext
-
Pharmacokinetically (PK)-guided dosing of paclitaxel in combination with carboplatin in advanced non-small cell lung cancer (NSCLC) is gender dependent : Updated results of the randomized CEPAC-TDM studyIn: European journal of cancer Jg. 51 (2015) Nr. S3: Abstracts from the European Cancer Congress 2015, S. 618ISSN: 0959-8049; 1879-0852; 1879-2995Online Volltext: dx.doi.org/
-
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 35, S. 4194 - 4201ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factorsIn: BMC Cancer Jg. 15 (2015) Nr. 1, S. 363ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
Second-line afatinib vs methotrexate (MTX) in patients (pts) with recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) : subgroup/biomarker analysis of LUX-head and neck 1 (LUX-H&N1)In: Annals of oncology Jg. 26 (2015) Nr. S 9: ESMO Asia Congress, 18-21 December 2015, Singapore : Submitted Abstracts, S. 93ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/
-
TEMHEAD : a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)In: Annals of Oncology Jg. 26 (2015) Nr. 3, S. 561 - 567ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access)
-
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neckIn: Cancer Chemotherapy and Pharmacology Jg. 73 (2014) Nr. 6, S. 1227 - 1239ISSN: 1432-0843Online Volltext: dx.doi.org/
-
Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non–Small-Cell Lung Cancer PatientsIn: Clinical Lung Cancer Jg. 15 (2014) Nr. 5, S. 320 - 330.e3ISSN: 1525-7304; 1938-0690Online Volltext: dx.doi.org/
-
CETUXIMAB (C), FLUOROURACIL (F) AND CISPLATIN (P) ALONE OR WITH DOCETAXEL (D) FOR RECURRENT/METASTATIC (RM) HEAD AND NECK CANCER (HNSCC) : FINAL ANALYSIS OF AIO TRIAL # 1108 - CEFCIDIn: Annals of Oncology Jg. 25 (2014) S. iv340ISSN: 1569-8041Online Volltext: dx.doi.org/ (Open Access)
-
Circulating tumor cell composition and outcome in patients with solid tumorsIn: International Journal of Clinical Pharmacology and Therapeutics Jg. 52 (2014) Nr. 1, S. 74 - 75ISSN: 0946-1965Online Volltext: dx.doi.org/
-
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck : Results of the randomized phase I/II ADVANTAGE trial (phase II part)In: Annals of Oncology Jg. 25 (2014) Nr. 3, S. 682 - 688ISSN: 1569-8041Online Volltext: dx.doi.org/ (Open Access)
-
Correlation of proteomics and first-line platinum-based chemotherapy in stage NSCLC in a large single-center cohortIn: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl.,ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III StudyIn: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 1 Suppl., S. S146 - S147ISSN: 0360-3016Online Volltext: dx.doi.org/
-
Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC)In: PLoS ONE Jg. 9 (2014) Nr. 12, S. e113706ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer PatientsIn: PLoS ONE Jg. 9 (2014) Nr. 1, S. e85350ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancerIn: Future Oncology Jg. 10 (2014) Nr. 5, S. 823 - 833ISSN: 1744-8301; 1479-6694Online Volltext: dx.doi.org/
-
First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy : analysis of a registry of the German Testicular Cancer Study Group (GTCSG)In: Journal of Cancer Research and Clinical Oncology Jg. 140 (2014) Nr. 7, S. 1211 - 1220ISSN: 0171-5216; 1432-1335Online Volltext: dx.doi.org/
-
Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapyIn: Cell Death and Disease Jg. 5 (2014) Nr. 2, S. e1091ISSN: 2041-4889Online Volltext: dx.doi.org/ (Open Access)
-
Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatmentIn: Translation Lung Cancer Research Jg. 3 (2014) Nr. 2, S. 100 - 106ISSN: 2218-6751Online Volltext: dx.doi.org/ (Open Access)
-
Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagusIn: Diseases of the Esophagus Jg. 27 (2014) Nr. 7, S. 678 - 684ISSN: 1120-8694; 1442-2050Online Volltext: dx.doi.org/
-
PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer : a translational subgroup analysis from AIO-PK0104In: BMC Cancer Jg. 14 (2014) Nr. 1, S. 624ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 7510ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Preclinical and clinical development of afatinib : a focus on breast cancer and squamous cell carcinoma of the head and neckIn: Future Oncology Jg. 10 (2014) Nr. 1, S. 21 - 40ISSN: 1744-8301; 1479-6694Online Volltext: dx.doi.org/
-
Successful resuscitation of a patient with ventricular fibrillation due to hypomagnesemia under cetuximab therapyIn: TumorDiagnostik & Therapie Jg. 35 (2014) Nr. 1, S. 25 - 27ISSN: 1439-1279; 0722-219XOnline Volltext: dx.doi.org/
-
Therapy of mRCC beyond mTOR-inhibition in clinical practice : results of a retrospective analysisIn: Journal of Cancer Research and Clinical Oncology Jg. 140 (2014) Nr. 5, S. 823 - 827ISSN: 0171-5216; 1432-1335; 0084-5353; 0943-9382Online Volltext: dx.doi.org/
-
Thoracic staging in lung cancer : prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CTIn: Journal of Nuclear Medicine (JNM) / Society of Nuclear Medicine and Molecular Imaging (SNMMI) (Hrsg.) Jg. 55 (2014) Nr. 3, S. 373 - 378ISSN: 1535-5667; 0161-5505; 2159-662X; 0022-3123; 0097-9058Online Volltext: dx.doi.org/ (Open Access)
-
Tumorrezidive der Kopf-Hals-Region nach PrimärtherapieIn: Der Onkologe Jg. 20 (2014) Nr. 2, S. 152 - 158ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
Using endobronchial valves to reduce irradiation portals in lung cancer : A case reportIn: Practical Radiation Oncology Jg. 4 (2014) Nr. 1, S. e91 - e94ISSN: 1879-8500Online Volltext: dx.doi.org/
-
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)In: Lung Cancer Jg. 82 (2013) Nr. 1, S. 83 - 89ISSN: 0169-5002Online Volltext: dx.doi.org/
-
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer : Markedly higher rate of pathologic complete remissions than with conventional fractionationIn: European Journal of Cancer Jg. 49 (2013) Nr. 9, S. 2107 - 2115ISSN: 0959-8049; 1879-0852Online Volltext: dx.doi.org/
-
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neckIn: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. 6065ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Biologische Therapie beim fortgeschrittenen LungenkarzinomIn: Deutsche Medizinische Wochenschrift: DMW Jg. 138 (2013) Nr. 40, S. 2034 - 2036ISSN: 1439-4413; 0012-0472Online Volltext: dx.doi.org/
-
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions : Initial resultsIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren Jg. 185 (2013) Nr. 11, S. 1056 - 1062ISSN: 0340-1618; 1438-9010; 1438-9029Online Volltext: dx.doi.org/
-
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer : Translational results from the randomised, crossover phase 3 trial AIO-PK0104In: British Journal of Cancer (BJC) Jg. 108 (2013) Nr. 2, S. 469 - 476ISSN: 1532-1827; 0007-0920Online Volltext: dx.doi.org/ (Open Access)
-
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterIn: European Journal of Cancer Jg. 49 (2013) Nr. 15, S. 3076 - 3082ISSN: 0959-8049; 1879-0852Online Volltext: dx.doi.org/
-
First-salvage treatment in patients with recurrent or refractory advanced germ-cell cancer after cisplatin-based chemotherapy : A database of the German Testicular Cancer Study GroupIn: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. 4559ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatmentIn: British Journal of Cancer (BJC) Jg. 109 (2013) Nr. 5, S. 1223 - 1229ISSN: 1532-1827; 0007-0920Online Volltext: dx.doi.org/ (Open Access)
-
Free soluble HLA-G molecules but not exosome-derived soluble HLA-G molecules are of prognostic relevance in lung cancer patientsIn: Tissue Antigens Jg. 81 (2013) Nr. 5, S. 282 - 283ISSN: 0001-2815; 1399-0039Online Volltext: dx.doi.org/
-
Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer : Final results of a randomised phase 3 trial of the 'arbeitsgemeinschaft internistische onkologie' (AIO-PK0104)In: Gut Jg. 62 (2013) Nr. 5, S. 751 - 759ISSN: 1468-3288; 0017-5749Online Volltext: dx.doi.org/
-
Hybrid [18F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI) : Preliminary results in non-small cell lung cancer (NSCLC)In: European Journal of Radiology: EJR Jg. 82 (2013) Nr. 11, S. 2055 - 2060ISSN: 0720-048X; 1872-7727Online Volltext: dx.doi.org/
-
Immuntherapie von Kopf-Hals-Karzinomen : Aktuelle EntwicklungenIn: HNO Jg. 61 (2013) Nr. 7, S. 559 - 572ISSN: 1433-0458Online Volltext: dx.doi.org/
-
Neue Entwicklungen in der Behandlung von soliden Tumoren mit zielgerichteten Medikamenten. Lunge, Niere, MelanomIn: Der Onkologe Jg. 19 (2013) Nr. 10, S. 821 - 834ISSN: 1433-0415Online Volltext: dx.doi.org/
-
Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy : A Multicenter Study of the Arbeitsgemeinschaft Internistische OnkologieIn: Oncology Jg. 84 (2013) Nr. 5, S. 284 - 289ISSN: 0030-2414; 1423-0232Online Volltext: dx.doi.org/
-
Phase II study of danusertib (D) in advanced/metastatic non-small cell lung cancers (NSCLC)In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. e19138ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neckIn: European Journal of Cancer Jg. 49 (2013) Nr. 13, S. 2877 - 2883ISSN: 0959-8049; 1879-0852Online Volltext: dx.doi.org/
-
Phase-I study of sagopilone in combination with cisplatin in chemotherapy-naive patients with metastasised small-cell lung cancerIn: European journal of cancer Jg. 49 (2013) Nr. 11, S. 2461 - 2468ISSN: 0959-8049; 1879-0852Online Volltext: dx.doi.org/
-
Phosphorylated ERK (pERK) as biomarker in patients with advanced pancreatic cancer treated with erlotinib within a randomized phase III trial (AIO-PK0104)In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 4 Suppl., S. 189ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Pre-therapeutic ex-vivo repair kinetics of cisplatin-DNA-adducts in circulating tumor cells (CTC) as platinum resistance testIn: Lung Cancer Jg. 79 (2013) Nr. Suppl. 1, S. 2ISSN: 0169-5002Online Volltext: dx.doi.org/
-
Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexedIn: Journal of Thoracic Oncology Jg. 8 (2013) Nr. 1, S. 19 - 30ISSN: 1556-1380; 1556-0864Online Volltext: dx.doi.org/
-
The 10th Annual Meeting of CESAR in Essen June 28 – 30, 2012, GermanyIn: International Journal of Clinical Pharmacology and Therapeutics Jg. 51 (2013) Nr. 1, S. 34ISSN: 0946-1965Online Volltext: dx.doi.org/
-
Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck : the phase II ADVANTAGE trialIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 193 - 194ISSN: 0378-584X; 1423-0240
-
Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck : The ADVANTAGE phase II trialIn: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15, S. 5516ISSN: 0732-183X; 1527-7755
-
Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexedIn: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 4, S. 766 - 767ISSN: 1556-1380; 1556-0864Online Volltext: dx.doi.org/ (Open Access)
-
Effektivität und Toxizität von bildgeführter hochkonformaler Bestrahlung multipler zerebraler Metastasen mit/ohne Ganzhirnbestrahlung (WBRT) mittels helikaler TomotherapieIn: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 41 - 42ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/
-
Erste Sicherheitsanalyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : Keine Signale für unerwartete Adverse Events/ToxizitätenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 188 (2012) Nr. Suppl. 1, S. 34ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/
-
Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural MesotheliomaIn: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, S. 1440 - 1448ISSN: 1556-1380; 1556-0864Online Volltext: dx.doi.org/ (Open Access)
-
Impact of EGFR mutation status on clinical benefit from BIBW 2992 in patients (PTS) with advanced non-small lung cancer (NSCLC) progressing after chemotherapy (CTX) and erlotinib (E) or gefitinib (G) - a single center experienceIn: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 437 - 438ISSN: 0923-7534; 1569-8041
-
Impact of HPV status on the response of head and neck cancers to the anti-EGFR antibody cetuximabIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 193 - 193ISSN: 0378-584X; 1423-0240
-
Improvement of histopathological Remission after neoadjuvant chemotherapy of accelerated hyperfractionation compared to conventional fractionation in locally advanced NSCLC (stage III)In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. Suppl. 1, S. 96 - 96ISSN: 0179-7158; 1439-099X
-
Investigation of Folate Receptor alpha and Thymidylate Synthase Proteins Expression in metastatic Non-Small Cell Lung Cancer Patients treated with Pemetrexed-based ChemotherapyIn: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, Suppl. 4, S. S211 - S212ISSN: 1556-0864; 1556-1380
-
Langzeitergebnisse nach Re-Radiotherapie bei Patienten mit einem Tumorrezidiv bzw. Zweitkarzinom im Kopf-Hals-BereichIn: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. Suppl. 1, S. 52ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/
-
Phase II trial of ptk787/zk 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage iiib/iv non-small-cell lung cancer (nsclc)In: Annals of Oncology Jg. 23 (2012) Nr. 3, S. 678 - 687ISSN: 1569-8041Online Volltext: dx.doi.org/
-
Phase i open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumoursIn: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 30 (2012) Nr. 5, S. 1962 - 1971ISSN: 0167-6997; 1573-0646Online Volltext: dx.doi.org/
-
Significance of Folate Receptor alpha (FRA) and Thymidylate Synthase (TS) expression in metastatic non-small cell lung cancer patients treated with pemetrexed-based chemotherapyIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 34ISSN: 0378-584X; 1423-0240
-
VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer CenterIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204ISSN: 0378-584X; 1423-0240
-
Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerIn: British Journal of Cancer (BJC) Jg. 107 (2012) Nr. 5, S. 823 - 830ISSN: 1532-1827; 0007-0920Online Volltext: dx.doi.org/ (Open Access)
-
10-year long-term survival (LTS) of induction (IND) chemotherapy (CTX) with three cycles cisplatin(P)/paclitaxel(T) followed by concurrent (CC) chemoradiation (CTX/RTX) P/Etoposide (ETO)/45 GY (1.5 GY BID) plus surgery (S) - A multicenter phase-II trial (Cistaxol)In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 494ISSN: 1556-0864; 1556-1380
-
15-Year (very) long-term survival (VLTS) and competing risks (CR) analysis of induction (IND) chemotherapy (CTX) with three cycles cisplatin (P) / etoposide (E) followed by concurrent (CC) chemoradiation (CTX/RTX) PE/45 GY (1.5 GY BID) pkus surgery (S) = TRIMIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S.S 492 - S493ISSN: 1556-0864; 1556-1380
-
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancerIn: Annals of Oncology Jg. 22 (2011) Nr. 8, S. 1798 - 1804ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access)
-
Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors : A Single-Center ExperienceIn: Hormone and Metabolic Research Jg. 43 (2011) Nr. 12, S. 838 - 843ISSN: 1439-4286Online Volltext: dx.doi.org/
-
Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trialsIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. S376 - S377ISSN: 1556-0864; 1556-1380
-
Decrease of circulating tumor cells associates with response to platinum-based chemotherapy in patients with non-small cell lung cancer, but not with small cell lung cancerIn: J Thorac Oncol Jg. 6 (2011) Nr. Suppl. 6, S. 1114ISSN: 1556-0864; 1556-1380
-
Dendritic cell generation and CD4+CD25HIGHFOXP3+regulatory regulatory t cells in human head and neck carcinoma during radio-chemotherapyIn: European Journal of Medical Research Jg. 16 (2011) Nr. 2, S. 57 - 62ISSN: 2047-783X; 0949-2321Online Volltext: dx.doi.org/ (Open Access)
-
Evaluation of betaV-tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer (NSCLC)In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 4, S. 14ISSN: 0959-8049
-
Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel TreatmentIn: Clinical Cancer Research Jg. 17 (2011) Nr. 15, S. 5197 - 5204ISSN: 1557-3265Online Volltext: dx.doi.org/
-
Highly sensitive detection of somatic epidermal growth factor receptor (EGFR) gene mutations in circulating tumor cells (CTC) from patients with non-small cell lung cancer treated with cisplatin/pemetrexed or afatinibIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S956 - S957ISSN: 1556-0864; 1556-1380
-
Hypofractionated image-guided radiotherapy (HF-IGRT) cerebral metastases by means of helical TomotherapyIn: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 19 - 19ISSN: 0179-7158; 1439-099X
-
Interference of amphiregulin and EGFRvIII expression with outcome of patients with squamous cell carcinoma of the head and neck (SCCHN) receiving cetuximab-docetaxel treatmentIn: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 5508ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7042ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Long-term survival (LTS) and competing risks within a prospective multicenter german randomized trial comparing induction (IND) chemotherapy (CTX) followed by concurrent (CC) chemoradiation (CTX/RTX) plus surgery (S) (= Trimodality) supplemented by PCI VEIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 495ISSN: 1556-0864; 1556-1380
-
Long-term survival (S) of induction chemotherapy (CTx) with three cycles cisplatin (cis)/paclitaxel (pac) followed by concurrent (cc) chemoradiation (CTx/RTx) cis/etoposide (eto) and 45 Gy (1.5 Gy bid) plus surgery (SURG) : Phase II results (CISTAXOL)In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7047ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Long-term survival results and prognostic factor analysis of two consecutive trimodality Phase-II trials in stage IIIA(N2) and selected stage IIIB non-small-cell lung cancer (NSCLC)In: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 68 - 69ISSN: 0179-7158; 1439-099X
-
Molecular markers of the EGFR pathway in erlotinib-treated patients with advanced pancreatic cancer (APC) : Translational analyses of a randomized, cross-over AIO phase III trialIn: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 4047ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Multimodale Therapie des lokal-fortgeschrittenen nichtkleinzelligen LungenkarzinomsIn: Der Onkologe Jg. 17 (2011) Nr. 8, S. 691 - 701ISSN: 0947-8965; 1433-0415Online Volltext: dx.doi.org/
-
Predictive value of thymidylate synthase and Folypoly-Glutamate Synthease for clinical benefit from pemetrexed in malignant pleural mesotheliomaIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S1092 - S1093ISSN: 1556-0864; 1556-1380
-
Predictive value of thymidylate synthase and folylpoly-glutamate synthetase for clinical benefit from pemetrexed in malignant pleural mesotheliomaIn: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7024ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Prevention, diagnosis, therapy, and follow-up of lung cancer : interdisciplinary guideline of the German respiratory society and the German cancer society abridged versionIn: Pneumologie Jg. 65 (2011) Nr. 8, S. e51 - e75ISSN: 0934-8387; 1438-8790Online Volltext: dx.doi.org/
-
Pseudomyxoma peritonei bei muzinösen ZystadenokarzinomenIn: Gynäkologische Praxis Jg. 35 (2011) Nr. 2, S. 273 - 280ISSN: 0341-8677
-
Re-Radiotherapie bei Patienten mit einem Tumorrezidiv bzw. Zweitkarzinom im Kopfhalsbereich
17. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik,In: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 28ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Renal cell carcinoma : Therapy management in Sequential therapyIn: Aktuelle Urologie Jg. 42 (2011) Nr. 3, S. A8 - A9ISSN: 1438-8820; 0001-7868
-
Very Late and Isolated Leptomeningeal Relapse of a Pulmonary Adenocarcinoma Presenting as DementiaIn: Onkologie Jg. 34 (2011) Nr. 6, S. 316 - 320ISSN: 1423-0240Online Volltext: dx.doi.org/
-
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer : an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'In: Anti-Cancer Drugs Jg. 21 (2010) Nr. 1, S. 94 - 100ISSN: 0959-4973; 1473-5741Online Volltext: dx.doi.org/
-
Imaging of Brain metastases of bronchial carcinomas with 7 T MRI initial resultsIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren Jg. 182 (2010) Nr. 9, S. 764 - 772ISSN: 0367-2239; 1438-9010; 0015-8151; 0340-1618; 0936-6652; 1433-5972; 1438-9029Online Volltext: dx.doi.org/
-
Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trialIn: International Journal of Radiation Oncology Biology Physics Jg. 76 (2010) Nr. 3, S. 809 - 815ISSN: 0360-3016; 1879-355XOnline Volltext: dx.doi.org/
-
Prävention, Diagnostik, Therapie und Nachsorge des LungenkarzinomsIn: Pneumologie Jg. 64 (2010) Nr. Suppl. 2, S. e1 - e164ISSN: 0934-8387; 1438-8790Online Volltext: dx.doi.org/
-
Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell TumoursIn: European Urology Jg. 57 (2010) Nr. 4, S. 679 - 687ISSN: 0302-2838; 1421-993XOnline Volltext: dx.doi.org/
-
Use of ERCC1 expression levels in circulating tumor cells to predict to response to platinum-based chemotherapy in patients with non-small cell lung cancerIn: Journal of Clinical Oncology (JCO) Jg. 28 S (2010) Nr. 15, S. Abstract7512ISSN: 0732-183X; 1527-7755
-
Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancerIn: Oncology Jg. 73 (2008) Nr. 5-6, S. 316 - 323ISSN: 0030-2414; 1423-0232Online Volltext: dx.doi.org/
-
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumourIn: European Respiratory Journal Jg. 29 (2007) Nr. 1, S. 117 - 127ISSN: 0903-1936; 1399-3003Online Volltext: dx.doi.org/ (Open Access)
-
Value of ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapyIn: Clinical Cancer Research Jg. 12 (2006) Nr. 1, S. 97 - 106ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
Erste Real-World Outcome-Daten von Patienten mit SCLC in Deutschland : Daten aus der Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 96ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Immuntherapie eines Mikrosatelliten-instabilen metastasierten Talgdrüsenkarzinoms der Glandula submandibularis mit Pembrolizumab
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 230 - 231ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Klinisch-dosimetrische Aspekte der Online-Planadaptation bei der kurativen Strahlentherapie lokal begrenzter urogenitaler Tumore : erste Erfahrungen mit dem Ethos®- System
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S71 - S72ISSN: 1439-099X; 0179-7158Online Volltext: dx.doi.org/ (Open Access) -
Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLCIn: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 65ISSN: 1556-1380; 1556-0864Online Volltext: dx.doi.org/
-
MRT-morphologische Charakteristika von niedrig malignen, orbitalen Non-Hodgkin Lymphomen nach kurativ intendierter Strahlentherapie : Bildgebende Remissionskriterien in der Langzeitbeobachtung
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S129ISSN: 1439-099X; 0179-7158Online Volltext: dx.doi.org/ (Open Access) -
Perspektiven für die tägliche adaptive online-onboard Strahlentherapie für Patientinnen mit Zervixkarzinom
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S25ISSN: 1439-099X; 0179-7158Online Volltext: dx.doi.org/ (Open Access) -
Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S15ISSN: 1439-099X; 0179-7158Online Volltext: dx.doi.org/ (Open Access) -
EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLCIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 142ISSN: 1439-099X; 0179-7158
-
Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world settingIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 812ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ (Open Access)
-
HANNA : Effectiveness and quality-of-life data from a real-world study of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab in GermanyIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 813ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ (Open Access)
-
Image-guided ablative Radiotherapy for Patients with multiple cerebral Metastases using Precision helical IrradiationIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 183ISSN: 1439-099X; 0179-7158
-
Long-term Follow-Up in Patients with Stage IAE Orbital Lymphoma and Radiotherapy with Photons : Monocentric ResultsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 58 - S59ISSN: 1439-099X; 0179-7158
-
Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the EsophagusIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 154 - S155ISSN: 1439-099X; 0179-7158
-
Re-Irradiation of cerebral Metastases after prophylactic Brain Skull irradiation in small-cell neuroendocrine Lung Cancer (SCLC)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 176ISSN: 1439-099X; 0179-7158
-
Systemic inflammatory response parameters as prognostic markers in patients with recurrent or metastatic head and neck cancer treated with immunotherapy
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 58ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Atmungs-kontrollierte Radiotherapie (RT) bei der Behandlung von Patienten mit Lungentumoren : Vorteile der „Inspiratorybreath- hold“-RT gegenüber dem Gating in Exspiration abhängig von der TumorlokalisationIn: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S42 - S43ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
DURTRERAD : A phase II open-label study evaluating feasibility and efficacy of durvalumab (D) and durvalumab and tremelimumab (DT) in combination with radiotherapy (RT) in non-resectable locally advanced HPV-negative HNSCC—Results of the preplanned feasibility interim analysisIn: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl., S. 6574ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Effectiveness and safety of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) - results from an observational study (HANNA) in Germany
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 132ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
HANNA : Real-world outcomes from an observational study with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in Germany.In: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl., S. 6532ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer IntentionIn: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S143ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
Modifikation der total nodalen Bestrahlung (TNI) als Teil der Konditionierung vor allogener Stammzelltransplantation (aSZT) bei hämatologischen Erkrankungen mittels helikaler Tomotherapie anhand einer retrospektiven KohorteIn: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. 105ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
Optimierung prognostischer Modelle für das Überleben von Patienten mit lokal fortgeschrittenen kleinzelligen Lungenkarzinomen nach definitiver Radiochemotherapie mittels künstlicher IntelligenzIn: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S57 - S58ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
Radiochemotherapie bei lokal fortgeschrittenen intra und extrahepatischen Gallenwegstumoren : niedriges Toxizitätsprofil bei hoch-konformalen Dosisverteilungen in Atem-getriggerter BestrahlungIn: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S153ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
HANNA : real-world evidence from a German, prospective, non-interventional study with nivolumab in patients with squamous cell carcinoma of the head and neck (SCCHN)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 57ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
HANNA : A National, Prospective, Non-Interventional Study of Nivolumab (Nivo) in Patients (pts) with Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing On or After Platinum-Based Therapy
33. Deutscher Krebskongress ; Perspektiven verändern Krebs – Krebs verändert Perspektiven, Diagnose – Therapie – (Über-)Leben ; 21. - 24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 14ISSN: 2296-5270; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
HANNA : A national, prospective, non-interventional study of Nivolumab (Nivo) in patients (Pts) with squamous cell carcinoma of the head and neck (SCCHN) progressing on or after platinum-based therapy
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 306ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ (Open Access) -
Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 109 - 110ISSN: 2296-5270; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 108ISSN: 2296-5270; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Three-Year Efficacy and Safety Update From the Phase III Checkmate 025 Study of Nivolumab (NIVO) v Everolimus (EVE) in Patients With Advanced Renal Cell Carcinoma (aRCC)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 78ISSN: 2296-5270; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Vergleich der 3D-Navigation der atemabhängigen Tumor-Position mittels stereoskopischer Röntgenaufnahmen (ExacTrac) bzw. kV-ConeBeam-CTs bei der kurativen Radiotherapie von LungenkarzinomenIn: Strahlentherapie und Onkologie Jg. 193 (2017) Nr. Suppl. 1, S. S79 - S80ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/
-
Evaluation of systemic inflammatory response (SIR) markers in recurrent or metastatic head and neck squamous cell carcinoma (r/m HNSCC)In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 307 - 308ISSN: 2296-5270Online Volltext: dx.doi.org/
-
18 F-FDG-Response als prognostischer Faktor für das progressionsfreie Überleben bei der Behandlung von lokal fortgeschrittenen, nichtkleinzelligen Lungenkarzinonem : Trimodale Therapie vs. definitive Radiochemotherapie – Monozentrische Ergebnisse
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl.1, S. S21 - S22ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
CheckMate 025 : a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)In: European Journal of Cancer Jg. 51 (2015) Nr. S3: Abstracts from the European Cancer Congress 2015, S. 708ISSN: 0959-8049; 1879-0852; 1879-2995Online Volltext: dx.doi.org/
-
Ganzhirnbestrahlung (WBRT) versus Ganzhirnbestrahlung mit bildgeführter stereotaktischer Bestrahlung multipler cerebraler Metastasen mittels helikaler Tomotherapie – Toxizitätsanalyse einer randomisierten Studie
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl.1, S. 149ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl. 1, S. 36 - 37ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Randomized study of individualized, pharmacokinetically-guided dosing of paclitaxel combined with carboplatin in advanced non-small cell lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 14 - 14ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ -
Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl. 1, S. 23ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
A single arm, open-label multicenter phase II trial of everolimus in patients with relapsed/refractory germ cell cancer (RADIT)In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. e15535ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Cetuximab (C), fluorouracil (F), and cisplatin (P) alone or with docetaxel (D) for recurrent/metastatic (RM) head and neck cancer (HNSCC) : First analysis of AIO trial # 1108In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. 6018ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 226 - 227ISSN: 2296-5262Online Volltext: dx.doi.org/ -
Circulating tumor cell composition and molecular markers in metastasized renal cell carcinoma (mRCC)
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 131ISSN: 2296-5262Online Volltext: dx.doi.org/ -
Circulating tumor cell subgroups and outcome in patients with non-small-cell-lung-cancer receiving platinum based treatment
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 89ISSN: 2296-5262Online Volltext: dx.doi.org/ -
DVH-Parameters and Toxicity of a dose increased Chemotherapy in locally advanced Squamous Cell Carcinoma (uT3/T4) of the Esophagus - Results of a prospective Phase I/II Study
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl.1, S. 109ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Definitive Radio Chemo Therapy for locally advanced Squamous Cell Carcinoma (uT3/T4) of the Esophagus with increased dose Radiation Therapy - Results of a Phase I/II Study (SPOT)
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl.1, S. 36 - 37ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl. 1, S. 5 - 6ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Impact of human papilloma virus infection on the response of head and neck cancers (HNSCC) to anti-epidermal growth factor receptor (EGFR) antibody therapy
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 76ISSN: 2296-5262Online Volltext: dx.doi.org/ -
Neoadjuvant Docetaxel/Cisplatin/5-FU based radiochemotherapy (RT-CT) increases pathologic complete remissions and survival of patients with locally advanced oral cavity carcinomas in comparison to RT-CT with cisplatin alone followed by resection – a long term observational study
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl.1, S. 79ISSN: 2296-5262Online Volltext: dx.doi.org/ -
P6-9 Neoadjuvante Radiochemotherapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Vergleich der Langzeitergebnisse zweier Protokolle
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl.1, S. 99 - 100ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl 1, S. 17ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl. 1, S. 17ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3ISSN: 2296-5262Online Volltext: dx.doi.org/ -
Akzeleriert-hyperfraktionierte Radiotherapie (RTx) mit simultaner Chemotherapie (CTx) im neoadjuvanten Konzept bei Stadium-III-Lungenkarzinom : signifikant höhere Rate pathologisch kompletter Remissionen (pCR) im Vergleich mit konventioneller Fraktionierung
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 19ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Akzelerierte Post-Pneumonektomie Salvage-Bestrahlung (RTx) mit simultaner Chemotherapie (CTx) bei Patienten mit kontralate - ralen zentralen Lungenkarzinomrezidiven
DEGRO 2013 19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 67ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Compliance-Analyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie – lassen sich Patienten lieber operieren?
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 87ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Prä-therapeutische ex-vivo Reparatur Kinetiken von Cisplatin-DNA-Addukten in Zirkulierenden Tumorzellen als Platin-Resistenz Test
119. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., 06. - 09. April 2013, Wiesbaden,In: Der Internist Jg. 54 (2013) Nr. Suppl. 1, S. 95 - 96ISSN: 0020-9554Online Volltext: dx.doi.org/ -
Vergleich einer neoadjuvanten Radiochemotherapie mit Docetaxel/Cisplatin/5-FU oder mit Cisplatin alleine beim lokal fortgeschrittenen Mundhöhlenkarzinom
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 100ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Accelerated Hyperfractionated Radiation Therapy Within Trimodality Therapy Concepts for Stage IIIa/b Non-small Cell Lung Cancer : Markedly Higher Rate of Pathologic Complete Remissions Than With Conventionally Fractionated RadiochemotherapyIn: International Journal of Radiation Oncology*Biology*Physics Jg. 84 (2012) Nr. 3, Suppl., S. S154ISSN: 0360-3016Online Volltext: dx.doi.org/
-
Einfluss der Induktions-Chemotherapie auf die Parameter der hochdosierten Radiochemotherapie beim lokal fortgeschrittenen LungenkarzinomIn: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 96ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/
-
Folylpoly-α-glutamate synthetase and thymidylate synthase are associated with clinical outcome from pemetrexed-based therapy in advanced non-small cell lung cancer (NSCLC)In: Cancer Research / AACR 103rd Annual Meeting 2012 ; Mar 31‐Apr 4, 2012, Chicago Jg. 72 (2012) Nr. 8, Suppl., S. 1713ISSN: 0008-5472; 1538-7445Online Volltext: dx.doi.org/
-
Neoadjuvante Therapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Induktionschemotherapie mit Docetaxel/Cisplatin/5-FU gefolgt von simultaner Strahlentherapie plus Docetaxel/Cisplatin gefolgt von OP – Phase-I-Studie: Ergebnisse und 3J-FUIn: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 90 - 90ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/
-
Postpneumonectomy Radical Accelerated (Re-)irradiation and Concurrent Chemotherapy for Patients With Contralateral Central Lung Cancer RelapsesIn: International Journal of Radiation Oncology, Biology, Physics / American Society for Radiation Oncology 54th Annual Meeting; 28-31 October 2012; Boston, USA Jg. 84 (2012) Nr. 3, Suppl. 1, S. 598ISSN: 0360-3016Online Volltext: dx.doi.org/
-
Dosisgesteigerte Strahlentherapie nach PET/CT-Planung in Kombination mit Induktions- und Simultaner Chemotherapie bei lokal fortgeschrittenen Platten-epithelkarzinomen (uT3/T4) des Ösophagus : Ergebnisse einer Phase I/II Studie (SPOT)
16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 186 (2010) Nr. Suppl. 1, S. 48ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Neoadjuvant therapy in stage III
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 7, S. 102 - 103ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Peritoneal mesothelioma
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 12 - 13ISSN: 0378-584X; 1423-0240; 2296-5270; 2296-5262Online Volltext: dx.doi.org/ -
Whole-body MRI in staging of Small cell Lung cancer (SCLC) : Detection of Bone metastases and that Osteoblastic Response - Phenomenon
Deutscher Krebskongress. Berlin 24.-27. Februar 2010,In: Oncology Research and Treatment Jg. 33 (2010) Nr. Suppl. 2, S. 123ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Zukunft der Therapie von Patienten mit metastasiertem Nierenzellkarzinom – Kombinationstherapie oder beste Therapiesequenz?In: Onkologie Jg. 33 (2010) Nr. Suppl. 2, S. 91ISSN: 0378-584X; 1423-0240; 2296-5270; 2296-5262Online Volltext: dx.doi.org/